{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T17:09:47.240339+00:00","company":{"ticker":"MDXG","cik":1376339,"company_name":"MIMEDX GROUP, INC."},"pagination":{"limit":100,"returned":2,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"d04833938d1a04cd3164f7b941dee3af998819c5","cik":1376339,"ticker":"MDXG","company_name":"MIMEDX GROUP, INC.","filed_at":"2026-04-29T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":"$11 million","period_text":"first quarter 2026","report_date":"2026-04-29","result_type":"reported_results","revenue_text":"$59 million"},"claim":"MIMEDX GROUP, INC. reported first quarter 2026 results: revenue $59 million, net income $11 million. Guidance lowered.","evidence_excerpt":"MIMEDX Announces First Quarter 2026 Operating & Financial Results Reports First Quarter Net Sales of $59 Million Revises 2026 Net Sales and Adjusted EBITDA Expectations","confidence":0.92,"filing_url":"https://secwatch.observer/filing/0001376339-26-000032","anchor_url":"https://secwatch.observer/filing/0001376339-26-000032#claim-d04833938d1a04cd3164f7b941dee3af998819c5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633926000032/0001376339-26-000032-index.htm"},{"fact_type":"earnings_release","fact_key":"515e88eee100980d588e39e86f612afa8aa8fe96","cik":1376339,"ticker":"MDXG","company_name":"MIMEDX GROUP, INC.","filed_at":"2024-04-30T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"GAAP Net Income was $9 Million","period_text":"first quarter ended March 31, 2024","report_date":"2024-04-30","result_type":"reported_results","revenue_text":"Net Sales of $85 Million"},"claim":"MIMEDX GROUP, INC. reported first quarter ended March 31, 2024 results: revenue Net Sales of $85 Million, net income GAAP Net Income was $9 Million.","evidence_excerpt":"MIMEDX Announces First Quarter 2024 Operating and Financial Results Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-125073","anchor_url":"https://secwatch.observer/filing/0001193125-24-125073#claim-515e88eee100980d588e39e86f612afa8aa8fe96","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1376339/000119312524125073/0001193125-24-125073-index.htm"}]}